Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives.
Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives.
复制标题
光反应性硝基苯基底物衍生物抑制急性髓系白血病细胞中的 UDP-GlcNAc:Gal beta 1-3GalNAc-R(GlcNAc 至 GalNAc)β 6-N-乙酰氨基葡萄糖转移酶。
DOI:
10.1006/bbrc.1994.1061
复制
发表时间:
1994
影响因子:
3.1
通讯作者:
Brockhausen,I
中科院分区:
文献类型:
--
作者:
Toki,D;Granovsky,MA;Reck,F;Kuhns,W;Baker,MA;Matta,KL;Brockhausen,I
Cells from patients with acute myeloid leukaemia (AML) contain an abnormally high UDP-GlcNAc:Galβ1-3Ga1NAc-R (GlcNAc to GalNAc) β6-N-acetylglucosaminyltransferase (core 2 β6-Gn-T) activity. Upon UV irradiation at 350 nm, the substrate Galβ1-3GalNAcα-p-nitrophenyl acted as an effective inhibitor for this enzyme but not for several other transferases. Preincubation with Galβ1-3GalNAcα-benzyl but not GalNAcα-benzyl protected core 2 β6-Gn-T from inhibition indicating that the inhibitor is specific for the substrate binding site of core 2 β6-Gn-T. A number of other nitrophenyl-sugar derivatives similarly acted as inhibitors for core 2 β6-Gn-T. GalNAcα-pnp at higher concernrations also inactivated UDP-Gal: GalNAc-R β3-galactosyltransferase from rat liver and AML cells and inhibition could be reduced by substrate protection. These results suggest that pnp-sugar derivatives may prove useful as specific inhibitors of glycosyltransferases and as affmity labels.